Is HUM stock a buy or a sell according to analysts?

Of the 44 analyst ratings on Humana Inc., 48% are Buy or Strong Buy, 22 are Hold, and 1 are Sell. The overall consensus rating is Hold. Analyst ratings are opinions, not investment advice.

What is the analyst price target for HUM?

The average analyst price target for Humana Inc. is $469.89. Individual targets range from $300.00 to $596.00.

When is Humana Inc.'s next earnings date?

Humana Inc. is scheduled to report earnings on November 6, 2026. Analysts expect earnings of $-1.00 per share.

Does Humana Inc. pay a dividend?

Yes — Humana Inc. has paid $3.54 per share in dividends over the trailing twelve months.

How volatile is HUM stock?

HUM has a beta of 0.74, meaning it has historically been less volatile than the broader market.

What sector is Humana Inc. in?

Humana Inc. operates in the Healthcare sector, the Medical - Healthcare Plans industry, and its stock trades on NYSE.

Back to Markets

Open HUM on Vela

Humana Inc.

HUM

0.00

USD

+0.00+0.00%

Overview Financials News Trades Technicals Forecast Transcripts

Humana Inc. at a glance

Open HUM on Vela

Humana Inc. (HUM) is a Healthcare company in the Medical - Healthcare Plans industry, headquartered in Louisville, KY, with about 67,060 employees. Its shares trade on NYSE, and its IPO date is December 31, 1981. With a market capitalization of $51.3 billion, HUM is a large-cap stock.

It trades an average of 1.4 million shares a day.

In its latest reported quarter (results released July 29, 2026), Humana Inc. posted revenue of $40.9 billion and earnings of $7.61 per share, against estimates of $40.6 billion and $7.27.

Figures as of October 14, 2026, from market data providers. Descriptive only, not financial advice.

HUM: Frequently asked questions

As of October 14, 2026, Humana Inc. has a market capitalization of $51.3 billion, making it a large-cap company in the Healthcare sector.

Figures update throughout the day from market data providers. Nothing on this page is financial advice.